These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pathogenic NFKB2 variant in the ankyrin repeat domain (R635X) causes a variable antibody deficiency. Tuijnenburg P; Lango Allen H; de Bree GJ; Savic S; Jansen MH; Stockdale C; Simeoni I; Ten Berge IJM; van Leeuwen EMM; ; Thaventhiran JE; Kuijpers TW Clin Immunol; 2019 Jun; 203():23-27. PubMed ID: 30953794 [TBL] [Abstract][Full Text] [Related]
8. [De novo NFκB2 gene mutation associated common variable immunodeficiency]. Luo MZ; Xu T; Xue XH; Wang YP; Wu PL; Chen XM; Tang XM; Zhao XD; Zhang ZY Zhonghua Er Ke Za Zhi; 2018 Aug; 56(8):628-632. PubMed ID: 30078247 [No Abstract] [Full Text] [Related]
9. A Case Report of Hypoglycemia and Hypogammaglobulinemia: DAVID Syndrome in a Patient With a Novel NFKB2 Mutation. Lal RA; Bachrach LK; Hoffman AR; Inlora J; Rego S; Snyder MP; Lewis DB J Clin Endocrinol Metab; 2017 Jul; 102(7):2127-2130. PubMed ID: 28472507 [TBL] [Abstract][Full Text] [Related]
10. Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies. Brue T; Quentien MH; Khetchoumian K; Bensa M; Capo-Chichi JM; Delemer B; Balsalobre A; Nassif C; Papadimitriou DT; Pagnier A; Hasselmann C; Patry L; Schwartzentruber J; Souchon PF; Takayasu S; Enjalbert A; Van Vliet G; Majewski J; Drouin J; Samuels ME BMC Med Genet; 2014 Dec; 15():139. PubMed ID: 25524009 [TBL] [Abstract][Full Text] [Related]
11. Novel NFKB2 mutation in early-onset CVID. Liu Y; Hanson S; Gurugama P; Jones A; Clark B; Ibrahim MA J Clin Immunol; 2014 Aug; 34(6):686-90. PubMed ID: 24888602 [TBL] [Abstract][Full Text] [Related]
12. Clinical, Immunological, and Genetic Features in Patients with NFKB1 and NFKB2 Mutations: a Systematic Review. Fathi N; Nirouei M; Salimian Rizi Z; Fekrvand S; Abolhassani H; Salami F; Ketabforoush AHME; Azizi G; Saghazadeh A; Esmaeili M; Almasi-Hashiani A; Rezaei N J Clin Immunol; 2024 Jul; 44(7):160. PubMed ID: 38990428 [TBL] [Abstract][Full Text] [Related]
13. Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2. Slade CA; McLean C; Scerri T; Giang TB; Megaloudis S; Strathmore A; Tempany JC; Nicholls K; D'Arcy C; Bahlo M; Hodgkin PD; Douglass JA; Bryant VL J Clin Immunol; 2019 Apr; 39(3):324-335. PubMed ID: 30927119 [TBL] [Abstract][Full Text] [Related]
14. Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells. Yeo SK; French R; Spada F; Clarkson R Breast Cancer Res Treat; 2017 Apr; 162(3):465-477. PubMed ID: 28190248 [TBL] [Abstract][Full Text] [Related]
15. Impairment of Mature B Cell Maintenance upon Combined Deletion of the Alternative NF-κB Transcription Factors RELB and NF-κB2 in B Cells. De Silva NS; Silva K; Anderson MM; Bhagat G; Klein U J Immunol; 2016 Mar; 196(6):2591-601. PubMed ID: 26851215 [TBL] [Abstract][Full Text] [Related]
16. NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: A case report and review of literature. Shi C; Wang F; Tong A; Zhang XQ; Song HM; Liu ZY; Lyu W; Liu YH; Xia WB Medicine (Baltimore); 2016 Oct; 95(40):e5081. PubMed ID: 27749582 [TBL] [Abstract][Full Text] [Related]
17. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2. Ishikawa H; Carrasco D; Claudio E; Ryseck RP; Bravo R J Exp Med; 1997 Oct; 186(7):999-1014. PubMed ID: 9314550 [TBL] [Abstract][Full Text] [Related]
18. A novel mutation in the Nfkb2 gene generates an NF-kappa B2 "super repressor". Tucker E; O'Donnell K; Fuchsberger M; Hilton AA; Metcalf D; Greig K; Sims NA; Quinn JM; Alexander WS; Hilton DJ; Kile BT; Tarlinton DM; Starr R J Immunol; 2007 Dec; 179(11):7514-22. PubMed ID: 18025196 [TBL] [Abstract][Full Text] [Related]
19. Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder. Keller MD; Pandey R; Li D; Glessner J; Tian L; Henrickson SE; Chinn IK; Monaco-Shawver L; Heimall J; Hou C; Otieno FG; Jyonouchi S; Calabrese L; van Montfrans J; Orange JS; Hakonarson H J Allergy Clin Immunol; 2016 Aug; 138(2):544-550.e4. PubMed ID: 27016798 [TBL] [Abstract][Full Text] [Related]
20. NFKB2 regulates human Tfh and Tfr pool formation and germinal center potential. De Leo P; Gazzurelli L; Baronio M; Montin D; Di Cesare S; Giancotta C; Licciardi F; Cancrini C; Aiuti A; Plebani A; Cicalese MP; Lougaris V; Fousteri G Clin Immunol; 2020 Jan; 210():108309. PubMed ID: 31751612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]